Investigational Drug Information for Radafaxine
✉ Email this page to a colleague
What is the development status for investigational drug Radafaxine?
Radafaxine is an investigational drug.
There have been 3 clinical trials for Radafaxine.
The most recent clinical trial was a Phase 2 trial, which was initiated on March 1st 2003.
The most common disease conditions in clinical trials are Disease, Depressive Disorder, Major, and Depressive Disorder. The leading clinical trial sponsors are GlaxoSmithKline and [disabled in preview].
Summary for Radafaxine
US Patents | 0 |
International Patents | 0 |
US Patent Applications | 581 |
WIPO Patent Applications | 203 |
Japanese Patent Applications | 55 |
Clinical Trial Progress | Phase 2 (2003-03-01) |
Vendors | 0 |
Recent Clinical Trials for Radafaxine
Title | Sponsor | Phase |
---|---|---|
An 8 Week Study Of Depression In Adults Diagnosed With Major Depressive Disorder | GlaxoSmithKline | Phase 2 |
An 8 Week Study Of Adults Diagnosed With Major Depressive Disorder | GlaxoSmithKline | Phase 2 |
An 8 Week Depression Study In Adults Diagnosed With Major Depressive Disorder | GlaxoSmithKline | Phase 2 |
Clinical Trial Summary for Radafaxine
Top disease conditions for Radafaxine
Top clinical trial sponsors for Radafaxine
US Patents for Radafaxine
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |